 IMAC Holdings, Inc. IMAC, a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,764,000 shares of common stock, par value 0.001 per share, at an offering price of 1.50 per share, pursuant to a registered direct offering. IMAC Holdings owns or manages 16 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. 